The innovative systemic treatments for psoriasis are a prime example of translational medicine. In a review published last year in the Journal of Investigative Dermatology, Prof. Peter van de Kerkhof, MD, former president of the European Society for Dermatological Research (ESDR) and chief medical officer at the International Psoriasis Council, provides an update on therapy-relevant immunopathogenetic concepts in psoriasis.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- DERMATOLOGIE PRAXIS
